T-cell suicide gene therapy prompts thymic renewal in adults after hematopoietic stem cell transplantation

Luca Vago, Giacomo Oliveira, Attilio Bondanza, Maddalena Noviello, Corrado Soldati, Domenico Ghio, Immacolata Brigida, Raffaella Greco, Maria Teresa Lupo Stanghellini, Jacopo Peccatori, Sergio Fracchia, Matteo Del Fiacco, Catia Traversari, Alessandro Aiuti, Alessandro Del Maschio, Claudio Bordignon, Fabio Ciceri, Chiara Bonini

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

The genetic modification of T cells with a suicide gene grants a mechanism of control of adverse reactions, allowing safe infusion after partially incompatible hematopoietic stem cell transplantation (HSCT). In the TK007 clinical trial, 22 adults with hematologic malignancies experienced a rapid and sustained immune recovery after T cell-depleted HSCT and serial infusions of purified donor T cells expressing the HSV thymidine kinase suicide gene (TK + cells). After a first wave of circulating TK+ cells, the majority of T cells supporting long-term immune reconstitution did not carry the suicide gene and displayed high numbers of naive lymphocytes, suggesting the thymus-dependent development of T cells, occurring only upon TK +-cell engraftment. Accordingly, after the infusions, we documented an increase in circulating TCR excision circles and CD31+ recent thymic emigrants and a substantial expansion of the active thymic tissue as shown by chest tomography scans. Interestingly, a peak in the serum level of IL-7 was observed after each infusion of TK+ cells, anticipating the appearance of newly generated T cells. The results of the present study show that the infusion of genetically modified donor T cells after HSCT can drive the recovery of thymic activity in adults, leading to immune reconstitution.

Original languageEnglish
Pages (from-to)1820-1830
Number of pages11
JournalBlood
Volume120
Issue number9
DOIs
Publication statusPublished - Aug 30 2012

Fingerprint

Gene therapy
T-cells
Hematopoietic Stem Cell Transplantation
Stem cells
Genetic Therapy
Suicide
T-Lymphocytes
Genes
Thymus
Recovery
Interleukin-7
Tissue Donors
Lymphocytes
Thymidine Kinase
Organized Financing
Hematologic Neoplasms
Tomography
Tissue
Thorax
Clinical Trials

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

T-cell suicide gene therapy prompts thymic renewal in adults after hematopoietic stem cell transplantation. / Vago, Luca; Oliveira, Giacomo; Bondanza, Attilio; Noviello, Maddalena; Soldati, Corrado; Ghio, Domenico; Brigida, Immacolata; Greco, Raffaella; Lupo Stanghellini, Maria Teresa; Peccatori, Jacopo; Fracchia, Sergio; Del Fiacco, Matteo; Traversari, Catia; Aiuti, Alessandro; Del Maschio, Alessandro; Bordignon, Claudio; Ciceri, Fabio; Bonini, Chiara.

In: Blood, Vol. 120, No. 9, 30.08.2012, p. 1820-1830.

Research output: Contribution to journalArticle

Vago, L, Oliveira, G, Bondanza, A, Noviello, M, Soldati, C, Ghio, D, Brigida, I, Greco, R, Lupo Stanghellini, MT, Peccatori, J, Fracchia, S, Del Fiacco, M, Traversari, C, Aiuti, A, Del Maschio, A, Bordignon, C, Ciceri, F & Bonini, C 2012, 'T-cell suicide gene therapy prompts thymic renewal in adults after hematopoietic stem cell transplantation', Blood, vol. 120, no. 9, pp. 1820-1830. https://doi.org/10.1182/blood-2012-01-405670
Vago, Luca ; Oliveira, Giacomo ; Bondanza, Attilio ; Noviello, Maddalena ; Soldati, Corrado ; Ghio, Domenico ; Brigida, Immacolata ; Greco, Raffaella ; Lupo Stanghellini, Maria Teresa ; Peccatori, Jacopo ; Fracchia, Sergio ; Del Fiacco, Matteo ; Traversari, Catia ; Aiuti, Alessandro ; Del Maschio, Alessandro ; Bordignon, Claudio ; Ciceri, Fabio ; Bonini, Chiara. / T-cell suicide gene therapy prompts thymic renewal in adults after hematopoietic stem cell transplantation. In: Blood. 2012 ; Vol. 120, No. 9. pp. 1820-1830.
@article{9bdda60d0ff94350b4a4b7028746f909,
title = "T-cell suicide gene therapy prompts thymic renewal in adults after hematopoietic stem cell transplantation",
abstract = "The genetic modification of T cells with a suicide gene grants a mechanism of control of adverse reactions, allowing safe infusion after partially incompatible hematopoietic stem cell transplantation (HSCT). In the TK007 clinical trial, 22 adults with hematologic malignancies experienced a rapid and sustained immune recovery after T cell-depleted HSCT and serial infusions of purified donor T cells expressing the HSV thymidine kinase suicide gene (TK + cells). After a first wave of circulating TK+ cells, the majority of T cells supporting long-term immune reconstitution did not carry the suicide gene and displayed high numbers of naive lymphocytes, suggesting the thymus-dependent development of T cells, occurring only upon TK +-cell engraftment. Accordingly, after the infusions, we documented an increase in circulating TCR excision circles and CD31+ recent thymic emigrants and a substantial expansion of the active thymic tissue as shown by chest tomography scans. Interestingly, a peak in the serum level of IL-7 was observed after each infusion of TK+ cells, anticipating the appearance of newly generated T cells. The results of the present study show that the infusion of genetically modified donor T cells after HSCT can drive the recovery of thymic activity in adults, leading to immune reconstitution.",
author = "Luca Vago and Giacomo Oliveira and Attilio Bondanza and Maddalena Noviello and Corrado Soldati and Domenico Ghio and Immacolata Brigida and Raffaella Greco and {Lupo Stanghellini}, {Maria Teresa} and Jacopo Peccatori and Sergio Fracchia and {Del Fiacco}, Matteo and Catia Traversari and Alessandro Aiuti and {Del Maschio}, Alessandro and Claudio Bordignon and Fabio Ciceri and Chiara Bonini",
year = "2012",
month = "8",
day = "30",
doi = "10.1182/blood-2012-01-405670",
language = "English",
volume = "120",
pages = "1820--1830",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "9",

}

TY - JOUR

T1 - T-cell suicide gene therapy prompts thymic renewal in adults after hematopoietic stem cell transplantation

AU - Vago, Luca

AU - Oliveira, Giacomo

AU - Bondanza, Attilio

AU - Noviello, Maddalena

AU - Soldati, Corrado

AU - Ghio, Domenico

AU - Brigida, Immacolata

AU - Greco, Raffaella

AU - Lupo Stanghellini, Maria Teresa

AU - Peccatori, Jacopo

AU - Fracchia, Sergio

AU - Del Fiacco, Matteo

AU - Traversari, Catia

AU - Aiuti, Alessandro

AU - Del Maschio, Alessandro

AU - Bordignon, Claudio

AU - Ciceri, Fabio

AU - Bonini, Chiara

PY - 2012/8/30

Y1 - 2012/8/30

N2 - The genetic modification of T cells with a suicide gene grants a mechanism of control of adverse reactions, allowing safe infusion after partially incompatible hematopoietic stem cell transplantation (HSCT). In the TK007 clinical trial, 22 adults with hematologic malignancies experienced a rapid and sustained immune recovery after T cell-depleted HSCT and serial infusions of purified donor T cells expressing the HSV thymidine kinase suicide gene (TK + cells). After a first wave of circulating TK+ cells, the majority of T cells supporting long-term immune reconstitution did not carry the suicide gene and displayed high numbers of naive lymphocytes, suggesting the thymus-dependent development of T cells, occurring only upon TK +-cell engraftment. Accordingly, after the infusions, we documented an increase in circulating TCR excision circles and CD31+ recent thymic emigrants and a substantial expansion of the active thymic tissue as shown by chest tomography scans. Interestingly, a peak in the serum level of IL-7 was observed after each infusion of TK+ cells, anticipating the appearance of newly generated T cells. The results of the present study show that the infusion of genetically modified donor T cells after HSCT can drive the recovery of thymic activity in adults, leading to immune reconstitution.

AB - The genetic modification of T cells with a suicide gene grants a mechanism of control of adverse reactions, allowing safe infusion after partially incompatible hematopoietic stem cell transplantation (HSCT). In the TK007 clinical trial, 22 adults with hematologic malignancies experienced a rapid and sustained immune recovery after T cell-depleted HSCT and serial infusions of purified donor T cells expressing the HSV thymidine kinase suicide gene (TK + cells). After a first wave of circulating TK+ cells, the majority of T cells supporting long-term immune reconstitution did not carry the suicide gene and displayed high numbers of naive lymphocytes, suggesting the thymus-dependent development of T cells, occurring only upon TK +-cell engraftment. Accordingly, after the infusions, we documented an increase in circulating TCR excision circles and CD31+ recent thymic emigrants and a substantial expansion of the active thymic tissue as shown by chest tomography scans. Interestingly, a peak in the serum level of IL-7 was observed after each infusion of TK+ cells, anticipating the appearance of newly generated T cells. The results of the present study show that the infusion of genetically modified donor T cells after HSCT can drive the recovery of thymic activity in adults, leading to immune reconstitution.

UR - http://www.scopus.com/inward/record.url?scp=84865708450&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865708450&partnerID=8YFLogxK

U2 - 10.1182/blood-2012-01-405670

DO - 10.1182/blood-2012-01-405670

M3 - Article

C2 - 22709689

AN - SCOPUS:84865708450

VL - 120

SP - 1820

EP - 1830

JO - Blood

JF - Blood

SN - 0006-4971

IS - 9

ER -